Chemotherapy: Balancing efficacy and minimizing side effects​

August 30, 2019
​​
Picture
By Dr Mastura Md Yusof​
Clinical Oncologist Consultant,
Pantai Hospital Kuala Lumpur. ​ 
​For decades, chemotherapy has remained a cornerstone in cancer treatment, despite its notoriety for causing distressing side effects. Simultaneously impacting normal tissues and a patient's overall physical well-being, the fear of chemotherapy has persisted. However, the landscape of cancer treatment is undergoing a profound transformation, driven by scientific advancements and the individualized approach fostered by clinical trials.

Chemotherapy in modern cancer treatment
The perspective on chemotherapy is evolving. Gone are the days of a one-size-fits-all approach. Instead, efforts are focused on improving chemotherapy's effectiveness while simultaneously mitigating its detrimental side effects.

Innovative approaches to enhance chemotherapy
In pursuit of this objective, a multitude of innovative strategies has emerged. There are groundbreaking approaches that specifically target cancer cells, such as liposomal therapy and monoclonal antibody therapy.

Additionally, drugs designed to minimize side effects, including colony-stimulating factors and chemoprotective agents like Dexrazoxane and Amifostine, are being incorporated into treatment regimens. Furthermore, anti-emetics are employed to alleviate chemotherapy-induced nausea and vomiting.

The rise of precision medicine and targeted therapies
The knowledge of precision medicine allows for a deeper understanding of tumor mutations and enables the customization of therapies to target specific abnormalities within tumors. Such targeted therapies are engineered to minimize damage to healthy cells that lack the identified abnormalities. Compared to traditional systemic treatments like chemotherapy, these tailored approaches often exhibit lower toxicity.

Harnessing immunotherapy for improved cancer outcomes
In addition to these advancements, the field has witnessed remarkable progress in the development of immunotherapy agents, particularly in the context of melanoma and lung cancer. Ongoing clinical trials are at the forefront of efforts to create safe and effective immunotherapy agents for various cancer types. Immunotherapy holds great promise in revolutionizing cancer treatment, offering new hope to patients around the world.